Veraxa Biotech AG Ordinary Shares (VRXA)

Price$20.00

All Metrics

Price vs S&P 500 (YTD)-19.86%

10-Day Avg Trading Volume0.03M

3-Month Avg Trading Volume0.03M

52-Week High$27.36

Year-to-Date Return-19.32%

Month-to-Date Return-19.32%

52-Week Low$15.25

Show chart for

About

Veraxa Biotech Holding AG is an oncology-focused biotechnology company. It is engaged in advancing the development of novel antibody-based drug platforms for the treatment of cancer. The Company originates from scientific discoveries made at the European Molecular Biology Laboratory. The Company's proprietary platform technologies enable the development of new generations of effective, targeted antibody-based cancer therapies. Such developments enable the Company to accelerate a pipeline of next-generation cancer therapies that have the potential to expand the therapeutic window of current solid tumor standard of care treatments through improved safety and efficacy profiles.